Thromboembolism and bleeding in systemic amyloidosis: a review

The assessment of both thromboembolic and haemorrhagic risks and their management in systemic amyloidosis have been poorly emphasized so far. This narrative review summarizes main evidence from literature with clinical perspective. The rate of thromboembolic events is as high as 5–10% amyloidosis pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicol, Martin, Siguret, Virginie, Vergaro, Giuseppe, Aimo, Alberto, Emdin, Michele, Dillinger, Jean Guillaume, Baudet, Mathilde, Cohen‐Solal, Alain, Villesuzanne, Camille, Harel, Stephanie, Royer, Bruno, Arnulf, Bertrand, Logeart, Damien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787981/
https://www.ncbi.nlm.nih.gov/pubmed/34784656
http://dx.doi.org/10.1002/ehf2.13701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787981/
https://www.ncbi.nlm.nih.gov/pubmed/34784656
http://dx.doi.org/10.1002/ehf2.13701

Ejemplares similares